05/27/2026
What if the parts of our DNA once dismissed as “dark matter” actually play a role in Alzheimer’s disease? With support from the McKnight Brain Institute and the Alzheimer’s Research Foundation, researchers are developing molecules designed to specifically target these proteins and test whether reducing them could positively impact disease models.
Progress in Alzheimer’s research doesn’t happen by playing it safe. It happens by asking difficult questions and daring to explore the unknown.
Support the future of breakthrough research. Consider making a monthly $25 donation today.